Track topics on Twitter Track topics that are important to you
Hilden, Germany, and Germantown, Maryland, January 23, 2018 – QIAGEN (NYSE: QGEN; Frankfurt Prime Standard: QIA) announced today that it has received clearance for its ipsogen JAK2 RGQ PCR Kit (i...
Hilden, Deutschland, und Germantown, Maryland (USA) (ots) - Der erweiterte Anwendungsbereich des ipsogen-Tests erfüllt die diagnostischen Testanforderungen der aktuellen WHO-Leitlinien für alle mye....
Qiagen's Ipsogen JAK2 RGQ PCR Kit was cleared by the FDA for diagnosing two more types of myeloproliferative neoplasms, namel -More-
Ipsogen foresees cancer, the second leading cause of death in developed countries, as a unique domain where drug development, commercialisation and prescription can benefit from biomarker discovery, v...
We have published hundreds of Ipsogen SA news stories on BioPortfolio along with dozens of Ipsogen SA Clinical Trials and PubMed Articles about Ipsogen SA for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Ipsogen SA Companies in our database. You can also find out about relevant Ipsogen SA Drugs and Medications on this site too.